InvestorsHub Logo
Followers 4
Posts 929
Boards Moderated 0
Alias Born 08/15/2006

Re: Doc328 post# 14833

Wednesday, 09/11/2019 11:32:31 AM

Wednesday, September 11, 2019 11:32:31 AM

Post# of 21544
Thanks doc, for your insights. Very thorough, very upfront.

I know you say that you think AD is dead, but do you think there would be any merit to exploring a small trial for those with early onset AD? I think it involves a genetic defect that affects AP0e4.

The reason I mention this is because of the compassionate-use patient, Jenny Spencer, who reportedly did so well on Bryostatin.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SNPX News